This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

Pancreatic cancer is an increasingly common cause of cancer mortality with a tight
correspondence between disease mortality and incidence. Furthermore, it is usually …

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic,
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …

Key Points Pancreatic Cysts Pancreatic cysts are common and are being discovered at an
increasing rate on cross-sectional imaging, but only a minority progress to cancer. The most …

Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …

Background & Aims There is substantial interest in liquid biopsy approaches for cancer early
detection among subjects at risk, using multi-marker panels. CA19-9 is an established …

Background Rapid access to pancreatic imaging and regular pancreatic surveillance may
help identify stage I pancreatic cancer. We investigated recent trends in the stage of newly …

Diese Leitlinie umfasst erstmals die akute wie auch die chronische Pankreatitis, um so
Übergänge der beiden ehemals getrennt wahrgenommenen Krankheitsbilder gemäß einem …

Background & aims Pancreatic cystic lesions (PCLs) are frequent incidental findings. As
most PCLs require costly diagnostic evaluation and active surveillance, it is important to …